接触一氧化碳工人血清LDL—C,HDL—C及脂质过氧化物含量的研究

本文对长期接触一氧化碳(CO)的工人血清高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)、甘油三脂(TG)及脂质过氧化物(LPO)含量进行了研究。结果表明,长期接触低浓度CO者的血清TG、LPO及HbCO含量与对照组比较,有极显著性差异(P<0.001)。     

高效液相色谱法测定头孢他啶血药浓度

目的建立测定头孢他啶血药浓度的方法。方法高效液相色谱法采用Kromasil C18色谱柱（250mm×4．6mm，5μm），以甲醇-磷酸二氢钾溶液（15：85）为流动相，流速1．0ml／min，检测波长254nm。结果头孢他啶吼浆浓度在0．5～200．0mg·L^-1范围内线性笑系良好（r=0．9999）。低、中、高3个浓度的方法回收率为94．91％～105．95％，RSD〈12％；提取回收率为89．50％～92．94％，RSD〈5％。结论本方法简便、准确、精密度好，可用于临床药动学研究。     

保肝解毒胶囊对雷公藤多甙片所致小鼠急性肝损伤保护作用的实验研究

目的：运用新建雷公藤多甙致小鼠急性肝损伤模型，探讨保肝解毒胶囊对该模型肝损伤保护作用的效果和机理。方法：连续5d给小鼠灌服保肝解毒胶囊制剂，而后以雷公藤多甙片造小鼠急性肝损伤模型，检测小鼠血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、还原型谷胱甘肽(GSH-Px)、超氧化物歧化酶(SOD)，肝匀浆中过氧化物(LPO)含量，并取肝组织作病理检查。结果：保肝解毒胶囊可以对抗肝损伤，其疗效和剂量有关；保肝解毒胶囊保护肝细胞的机理与对抗脂质过氧化反应有关。结论：保肝解毒胶囊具有保护肝脏的作用，     

2型糖尿病并脂肪肝与血脂紊乱的关系探讨

目的　探讨 2型糖尿病并脂肪肝患者与脂代谢紊乱之间的关系。方法　对 60例 2型糖尿病并脂肪肝和 5 2例 2型糖尿病不并有脂肪肝病例的血脂谱 ,空腹血糖 (FPG ) ,餐后 2小时血糖 ( 2hPG) ,空腹胰岛素 (FINS)进行测定 ,计算体重指数 (BMI)及胰岛素敏感指数 (ISI)。结果　 2型糖尿病并脂肪肝与不并脂肪肝相比 ,甘油三脂 (TG) ,低密度脂蛋白胆固醇 (LDL -C) ,FINS均升高 (P <0 .0 5 ,P <0 .0 1) ,而ISI明显降低 (P <0 .0 1)、脂蛋白a(Lp(a)降低(P <0 .0 5 )。结论　 2型糖尿病并脂肪肝比不并脂肪肝者存在明显脂代谢紊乱及胰岛素抵抗     

Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjects

Hexobarbital (HB) concentrations were determined in plasma and saliva of 8 healthy subjects, following oral administration of 500 mg HB-Na. Mean plasma half-lives were 3.2 +/- 0.1 h, and salivary half-lives 3.3 +/- 0.2 h. Mean plasma clearance was 22.9 +/- 2.3 1 h-1. There was a linear relationship between HB concentrations in saliva and plasma (r = 0.92). Mean salivary levels were 34 per cent of plasma levels. Salivary pH was constant throughout the experiment, 7.06 +/- 0.09. There was an inconsistent tendency of the saliva over plasma ratios to increase as a function of time. The percentage of protein binding calculated from saliva over plasma ratios was in reasonable agreement with in vitro data of equilibrium dialysis, 64.1 +/- 2.6 per cent and 65.9 +/- 0.8 per cent, respectively. The experiment was repeated in 4 subjects, and considerable intraindividual differences were shown to exist in saliva over plasma ratio, half-lives, and protein binding. It was concluded that HB elimination half-lives can relatively accurately be determined from salivary concentrations. Oral plasma clearance can only be estimated if the individual saliva over plasma ratios are known; this would require the taking of at least one blood sample during the experiment. When employing HB as a model substrate for drug metabolizing enzyme activity in vivo, the determination of its pharmacokinetic parameters, particularly oral plasma clearance as a reflection of cytochrome P-450 activity, cannot be achieved by taking saliva samples only.     

PNH者患红细胞膜结构损伤及膜脂与膜蛋白关系的探索

本文分析了20例PNH患者红细胞膜总脂,Ch/PIM比及磷脂组分,并比较了10例PNH红细胞膜AChE在PBS系统和生理盐水中的酶活性。发现PNH红细胞膜脂缺失严重,比正常少22％,但Ch/PIM比值及各磷脂相对含量均无明显改变。在PBS中AChE活性接近正常红细胞,但在生理盐水中明显低于正常红细胞,仅为正常的40％。表明PNH红细胞对补体敏感而溶血可能是由于补体导致膜脂缺失,进而破坏了红细胞膜结构的完整性而引起的,这也是AChE活性在低pH环境中酶活性比正常红细胞低的原因。     

N-(Acyloxyalkoxycarbonyl) derivatives as potential prodrugs of amines. II. esterase-catalysed release of parent amines from model prodrugs

N-(Acetoxyethoxycarbonyl) derivatives of primary amines released a major fraction of the parent amine in the desired free form in plasma but a significant fraction of the undesired N-acetylated parent amine was also produced. The fraction of the parent amines released from the carbamate derivatives of the primary amines was greater in human plasma than in pH 7.4 buffer. In human plasma, the N-(acetoxyethoxycarbonyl) derivative of a secondary amine released the parent amine in a quantitative manner at a rate higher than that observed in pH 7.4 buffer. Experimental results suggested that the observed catalysis of the release of the parent amines from N-(acetoxyethoxycarbonyl) derivatives of primary and secondary amines was due to participation by plasma esterases. The data suggested that N-(acetoxyethoxycarbonyl) derivatives are well suited for use as prodrugs of secondary amines. Their utility as prodrugs of primary amines is more problematic and cannot be predicted prior to in-vivo studies for the individual compound.     

羧乙基锗倍半氧化物(Ge-132)在大鼠乙醇中毒过程中的抗氧化作用

目的 探讨羧乙基锗倍半氧化物（Ge-132)在乙醇致体内脂质过氧化过程的抑制作用及机理。方法 用10mg/kg体重的乙醇给大鼠灌胃，同时自由饮用100mg/L的锗－132，饲养3个月。结果 乙醇＋Ge-132组大鼠组织和血清与单给乙醇组比较DMA含量显著降低（P＜0．05），SOD、CAT活力均升高（P＜0．05），但与对照组比较均无显著性差异（P＞0．05）。结论 Ge-132通过清除OH^.和O2^.-自由基，抑制SOD、CAT活力降低，从而抑制过量乙醇对机体的损伤。     

Effect of intraperitoneally injected fluoride on plasma calcium in suckling and adult rats

Summary Sodium fluoride 10, 20, or 40 mg/kg body weight was given intraperitoneally to rats (6–11 days old and 90–95 days old). Blood analyses showed an initial increase in plasma fluoride concentration. The subsequent decrease in fluoride was paralleled by a decrease in total plasma calcium. These plasma concentrations were normal at blood collection 4 days after fluoride injection. The baby rats differed from the older rats in that their initial plasma calcium was higher and that the drop in plasma calcium concentration was less pronounced than in the old rats. A diet low in calcium and phosphate enhanced the effects of fluoride on total plasma calcium. The data indicate that the effect of large doses of fluoride on lowering the plasma calcium level is modified by the calcium intake.     

老年人高粘滞血症预防的初步探讨

本文报告对32例60岁以上健康老年人预防高粘滞血症的观察结果.经采取综合预防措施六年,血流变学检测表明:全血(比)粘度、血浆(比)粘度、血沉、红细胞压积均低于对照组,统计学处理表明,前三项指标P值均小于0.01,因此达到了对老年人高粘滞血症的预防目的.